While the data collected in HOS can be usedto provide only general information on changes in liver and spleen size, this stillprovides valuable information on the effects of idursulfase treatment upon thiscommon clinical manifestation of MPS II. The gene discussed is IDS; the disease is mucopolysaccharidosis type 2.